InspireMD (NSPR) has released an update to notify the public and investors about a regulation fd disclosure.
InspireMD, Inc. announced on January 31, 2024, that it has received CE Mark recertification under the new Medical Device Regulation (MDR) framework of the European Union, which confirms compliance with the updated regulatory standards. This information, along with the related press release, was reported in a Current Report on Form 8-K but is not considered filed for legal purposes and is not incorporated by reference into any other regulatory filings.
For further insights into NSPR stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
